Highly accelerated first‐pass contrast‐enhanced magnetic resonance angiography of the peripheral vasculature: Comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents
Authors:
- 23 October 2009
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 30 (5) , 1085-1092
Abstract
Purpose: To investigate the blood pool agent gadofosveset trisodium for first‐pass, dynamic peripheral contrast‐enhanced magnetic resonance angiography (pMRA), and compare the results with a conventional gadolinium contrast agent.Materials and Methods: A total of 16 patients were imaged at 1.5T using a prototype peripheral vascular coil with high SENSE acceleration. Five received gadopentetate dimeglumine (≈0.25 mmol/kg), and 11 received gadofosveset trisodium (five standard‐dose 0.03 mmol/kg, six high‐dose 0.05 mmol/kg). Quantitative contrast‐enhancement and qualitative image quality evaluation was compared between agents and doses.Results: High‐quality diagnostic images were uniformly obtained. The contrast ratio did not significantly differ between gadopentetate dimeglumine and high‐dose gadofosveset trisodium, both of which were greater than standard‐dose gadofosveset trisodium. High‐dose gadofosveset trisodium was equivalent to gadopentetate dimeglumine in image quality and subjective vessel‐to‐background ratio, but significantly better for depicting small muscular arteries. Standard‐dose gadofosveset trisodium showed equivalent image quality and small artery depiction with a slight but significant decrease in vessel‐to‐background ratio as compared to gadopentatate dimeglumine. Both gadofosveset trisodium doses trended toward more venous enhancement, but this was not a diagnostic problem.Conclusion: First‐pass peripheral CE‐MRA using gadofosveset trisodium is feasible, yielding image quality comparable to double to triple‐dose gadopentetate dimeglumine. Increasing the gadofosveset trisodium dose to 0.05 mmol/kg yields further improvements. J. Magn. Reson. Imaging 2009;30:1085–1092.Keywords
This publication has 26 references indexed in Scilit:
- Peripheral moving-table contrast-enhanced magnetic resonance angiography (CE-MRA) using a prototype 18-channel peripheral vascular coil and scanning parameters optimized to the patient's individual hemodynamicsJournal of Magnetic Resonance Imaging, 2009
- First-Pass Whole-Body Magnetic Resonance Angiography (MRA) Using the Blood-Pool Contrast Medium Gadofosveset TrisodiumInvestigative Radiology, 2007
- Measurement of signal‐to‐noise ratios in MR images: Influence of multichannel coils, parallel imaging, and reconstruction filtersJournal of Magnetic Resonance Imaging, 2007
- Peripheral MR AngiographyJournal of Cardiovascular Magnetic Resonance, 2006
- Species Dependence on Plasma Protein Binding and Relaxivity of the Gadolinium-Based MRI Contrast Agent MS-325Investigative Radiology, 2006
- Use of a three‐station phased array coil to improve peripheral contrast‐enhanced magnetic resonance angiographyJournal of Magnetic Resonance Imaging, 2004
- Contrast‐enhanced MR angiography of the run‐off vasculature: Intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumineJournal of Magnetic Resonance Imaging, 2003
- Contrast-Enhanced Peripheral MR Angiography from the Abdominal Aorta to the Pedal ArteriesInvestigative Radiology, 2001
- Stepping-Table Gadolinium- enhanced Digital Subtraction MR Angiography of the Aorta and Lower Extremity Arteries: Preliminary ExperienceRadiology, 1999
- Optimizing Three-Dimensional Gadolinium-Enhanced Magnetic Resonance AngiographyInvestigative Radiology, 1998